References



These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

*For best results, consume within 30mins after mixing. Do not mix with carbonated drinks

  1. Swidsinski, A., Loening-Baucke,V., Verstraelen, H., Osowska, S., & Doerffel, Y. (2008). Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology, 135(2), 568-579.
  2. Martins, F.S., Silva, A.A., Vieira, A.T., Barbosa, F.H., Arantes, R.M., et al. (2009). Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Archives of Microbiology, 191, 623-630.
  3. Klein, S.M., Elmer, G.W., McFarland, L.V., Surawicz, C.M., & Levy, R.H. (1993). Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharmaceutical Research, 10, 1615-1619.
  4. Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. (2002). Guidelines for the Evaluation of Probiotics in Food. London Ontario, Canada: FAO/WHO.
  5. Buts, J.P., Bernasconi, P., Van Craynest, M.P., Maldague, P., & De Meyer, R. (1986). Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatric Research, 20, 192-196.
  6. Schneider, S.M., Girard-Pipau, F., Filippi,J., Hebuterne, X., Moyse, D., et al. (2005). Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World Journal of Gastroenterology, 11, 6165-6169.
  7. Vandenplas, Y., Brunser, O., & Szajewska, H. (2009). Saccharomyces boulardii in childhood. European Journal of Pediatrics, 168(3), 253-265.
  8. Blehaut, H., Massot, J., Elmer, G.W., & Levy, R.H. (1989). Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharmaceutics & Drug Disposition, 10(4), 353-364.
  9. IMS Data, 2015.

Follow Us